Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Virtual Reality Mindfulness Meditation After ACL Reconstruction 09/02/2022 INTERVENTIONAL not-comparable 1,499.75 0 First in Human Study of IMGN151 in Recurrent Gynaecological Cancers 09/02/2022 INTERVENTIONAL not-comparable 1,499.75 0 Trans-RosaLEE Study: a Biomarker-directed, Translational Study 09/07/2022 INTERVENTIONAL not-comparable 1,494.75 0 Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer 09/07/2022 INTERVENTIONAL not-comparable 1,494.75 0 Appetitive Conditioning in Anorexia Nervosa 09/08/2022 OBSERVATIONAL not-comparable 1,493.75 0 Internet CBT for Antenatal Depression 09/08/2022 INTERVENTIONAL not-comparable 1,493.75 0 The Oklahoma Parent-Child Assistance Program 09/09/2022 INTERVENTIONAL not-comparable 1,492.75 0 Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women 09/10/2022 INTERVENTIONAL not-comparable 1,491.75 0 TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients 09/10/2022 INTERVENTIONAL not-comparable 1,491.75 0 UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases 09/10/2022 INTERVENTIONAL not-comparable 1,491.75 0 WAKIX® (Pitolisant) Pregnancy Registry 09/10/2022 OBSERVATIONAL not-comparable 1,491.75 0 Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog) 09/13/2022 INTERVENTIONAL not-comparable 1,488.75 0 Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer 09/13/2022 INTERVENTIONAL not-comparable 1,488.75 0 Platelet Rich Plasma for Insufficient Endometrium 09/13/2022 INTERVENTIONAL not-comparable 1,488.75 0 Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers 09/14/2022 INTERVENTIONAL not-comparable 1,487.75 0 ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer 09/15/2022 INTERVENTIONAL not-comparable 1,486.75 0 Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes 09/16/2022 INTERVENTIONAL not-comparable 1,485.75 0 ED90 of Epidural Bupivacaine With Lidocaine for the Initiation of Labor Analgesia 09/16/2022 INTERVENTIONAL not-comparable 1,485.75 0 Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women 09/21/2022 INTERVENTIONAL not-comparable 1,480.75 0 A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma 09/21/2022 INTERVENTIONAL not-comparable 1,480.75 0 Reduced Opioid Prescription After Laparoscopic Hysterectomy 09/21/2022 INTERVENTIONAL not-comparable 1,480.75 0 Structured Contraceptive Counseling During Pregnancy 09/22/2022 INTERVENTIONAL not-comparable 1,479.75 0 The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer 09/22/2022 INTERVENTIONAL not-comparable 1,479.75 0 Safest Choice of Antihypertensive Regimen for Postpartum Hypertension 09/22/2022 INTERVENTIONAL not-comparable 1,479.75 0 Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi 09/22/2022 INTERVENTIONAL not-comparable 1,479.75 0 IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer 09/22/2022 INTERVENTIONAL not-comparable 1,479.75 0 Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women 09/23/2022 INTERVENTIONAL not-comparable 1,478.75 0 The Effect of ASTARTE™ on Recurrent Urinary Tract Infection 09/23/2022 INTERVENTIONAL not-comparable 1,478.75 0 Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health 09/23/2022 OBSERVATIONAL not-comparable 1,478.75 0 Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB 09/26/2022 INTERVENTIONAL not-comparable 1,475.75 0 Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial 09/26/2022 INTERVENTIONAL not-comparable 1,475.75 0 Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic 09/27/2022 INTERVENTIONAL not-comparable 1,474.75 0 Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors 09/27/2022 OBSERVATIONAL not-comparable 1,474.75 0 Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer 09/28/2022 INTERVENTIONAL not-comparable 1,473.75 0 Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer 09/28/2022 INTERVENTIONAL not-comparable 1,473.75 0 Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted 09/29/2022 INTERVENTIONAL not-comparable 1,472.75 0 Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma 09/29/2022 INTERVENTIONAL not-comparable 1,472.75 0 Can the Use of a Next Generation Partograph Improve Neonatal Outcomes? (PICRINO) 09/29/2022 INTERVENTIONAL not-comparable 1,472.75 0 Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries) 09/30/2022 OBSERVATIONAL not-comparable 1,471.75 0 Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk 10/03/2022 INTERVENTIONAL not-comparable 1,468.75 0 Women Hypertensive and Young-Renal Denervation 10/03/2022 INTERVENTIONAL not-comparable 1,468.75 0 Exploring Virtual Reality Adventure Training Exergaming 10/03/2022 INTERVENTIONAL not-comparable 1,468.75 0 Anal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV 10/04/2022 OBSERVATIONAL not-comparable 1,467.75 0 Testing Multi-Level Remote Physical Activity Interventions in a National Sample of Older Women: The WHISH EnCore Trial 10/04/2022 INTERVENTIONAL not-comparable 1,467.75 0 Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires 10/05/2022 OBSERVATIONAL not-comparable 1,466.75 0 Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study 10/05/2022 INTERVENTIONAL not-comparable 1,466.75 0 Evaluation of Young United Parents 10/06/2022 INTERVENTIONAL not-comparable 1,465.75 0 Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes 10/06/2022 INTERVENTIONAL not-comparable 1,465.75 0 A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 10/06/2022 INTERVENTIONAL not-comparable 1,465.75 0 1/2- Bangladesh Center for Global Environmental and Occupational Health- Bangladesh 10/06/2022 INTERVENTIONAL not-comparable 1,465.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology